The administration says the current practice of focusing on key risks is a loophole that needs to be closed.
Add Axios as your preferred source to
see more of our stories on Google.
Illustration: Megan Robinson / Axios
Those disclaimers in TV drug ads could get longer if the Trump administration makes good on plans to require all safety risks to be disclosed in the ads instead of referring consumers to another source.
The big picture: The administration says the current practice of focusing on key risks is a loophole that needs to be closed amid a proliferation of direct-to-consumer drug ads.
The Trump administration plans to ensure transparency and accuracy in drug ads, including by increasing the amount of information…
The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of…
The Trump administration is closing a loophole that drugmakers could use to avoid negotiations when they add active ingredients…
Offering hundreds of generic drugs on TrumpRx fills a key gap on the direct-to-consumer site.
Trump said he is increasing the number of products on the platform by nearly seven times, adding more than 600 generic drugs to…
Patients could save more buying non-branded copycat drugs, even if they don't have insurance.
